To assess plasma levels of HO-1 and IL-6 as complementary biomarkers of host response in a malaria-endemic population, highlighting their potential clinical significance.
Key Findings:
Microscopy-positive individuals had lower haemoglobin, haematocrit, red-cell count, and platelet counts compared to microscopy-negative individuals (p<0.001), indicating significant physiological differences.
IL-6 levels were significantly higher in malaria-positive individuals (median 141.28 vs 106.58 pg/mL; p=0.027), underscoring its role as an inflammatory marker.
HO-1 showed a non-significant increase in malaria-positive individuals (230.98 vs 193.73 ng/mL; p=0.131), suggesting limited utility as a biomarker.
IL-6 correlated positively with HO-1, parasitaemia, and temperature, and negatively with haemoglobin, indicating its multifaceted role in malaria pathology.
ROC analysis indicated IL-6 had moderate discriminatory ability (AUC 0.709) compared to HO-1 (AUC 0.641), emphasizing IL-6's potential as a diagnostic tool.
Interpretation:
IL-6 is a more effective inflammatory biomarker for malaria than HO-1, which requires further investigation to clarify its role.
Limitations:
Limited sample size for biomarker subset analysis may affect the robustness of findings.
Cross-sectional design may not capture temporal changes in biomarker levels, introducing potential biases.
Conclusion:
IL-6 could serve as a valuable adjunct inflammatory biomarker in malaria, while the role of HO-1 needs further validation in larger studies to establish its clinical relevance.
A retrospective cohort study of more than 520,000 hospitalized patients found no clinically meaningful improvement in deterioration or mortality with early treatment targeting community-acquired pneumonia.
